Key facts
- This page summarizes Miriam Provost's Form 4 filing for TransMedics Group, Inc. (TMDX).
- 10 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 15 Dec 2023, 17:31.
Miriam Provost - 13 Dec 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)
- Reporting relationship
- VP, Global Regulatory Affairs
- Issuer ticker
- TMDX
- Reported as of
- 13 Dec 2023
- Net transaction value
- -$56,648
- SEC form
- 4
- Accepted by SEC
- 15 Dec 2023, 17:31:17 UTC
- Prior SEC filing
- 05 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Stephen Gordon, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Miriam Provost filed Form 4 for TransMedics Group, Inc. (TMDX) on 15 Dec 2023.
Change
- Previous filing in this sequence was filed on 05 Sep 2023.
- Current net transaction value: -$56,648.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TMDX
transaction
Common Stock
Options Exercise
- Transaction value
- $6,698
- Shares
- +415
- Change %
- +1.8%
- Price
- $16.14
- Shares after
- 24,026
- Date
- 13 Dec 2023
- Ownership
- Direct
TMDX
transaction
Common Stock
Sale
- Transaction value
- $15,471
- Shares
- -206
- Change %
- -0.86%
- Price
- $75.10
- Shares after
- 23,820
- Date
- 13 Dec 2023
- Ownership
- Direct
- Footnotes
- F1
TMDX
transaction
Common Stock
Options Exercise
- Transaction value
- $107,875
- Shares
- +1,632
- Change %
- +6.9%
- Price
- $66.10
- Shares after
- 25,452
- Date
- 13 Dec 2023
- Ownership
- Direct
TMDX
transaction
Common Stock
Sale
- Transaction value
- $113,326
- Shares
- -1,509
- Change %
- -5.9%
- Price
- $75.10
- Shares after
- 23,943
- Date
- 13 Dec 2023
- Ownership
- Direct
- Footnotes
- F1
TMDX
transaction
Common Stock
Options Exercise
- Transaction value
- $138,341
- Shares
- +3,597
- Change %
- +15%
- Price
- $38.46
- Shares after
- 27,540
- Date
- 13 Dec 2023
- Ownership
- Direct
TMDX
transaction
Common Stock
Sale
- Transaction value
- $180,766
- Shares
- -2,407
- Change %
- -8.7%
- Price
- $75.10
- Shares after
- 25,133
- Date
- 13 Dec 2023
- Ownership
- Direct
- Footnotes
- F1
TMDX
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -1,785
- Change %
- -7.1%
- Price
- $0.000000
- Shares after
- 23,348
- Date
- 15 Dec 2023
- Ownership
- Direct
- Footnotes
- F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TMDX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -415
- Change %
- -5%
- Price
- $0.000000
- Shares after
- 7,811
- Date
- 13 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 415
- Exercise price
- $16.14
- Footnotes
- F4
TMDX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -1,632
- Change %
- -19%
- Price
- $0.000000
- Shares after
- 7,073
- Date
- 13 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,632
- Exercise price
- $66.10
- Footnotes
- F5
TMDX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -3,597
- Change %
- -32%
- Price
- $0.000000
- Shares after
- 7,813
- Date
- 13 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,597
- Exercise price
- $38.46
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.
Footnote F2
On December 15, 2023, the reporting person donated 1,785 shares of directly owned common stock to a donor-advised fund, which will use the gifted shares for charitable purposes.
Footnote F3
Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F4
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.
Footnote F5
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 20, 2023.
Footnote F6
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.